Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) closed the day trading at $0.47 down -10.92% from the previous closing price of $0.53. In other words, the price has decreased by -$10.92 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
For a better understanding of SXTP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.91 and its Current Ratio is at 5.26. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when XU CHERYL bought 6,000 shares for $1.56 per share. The transaction valued at 9,375 led to the insider holds 52,078 shares of the business.
XU CHERYL bought 5,000 shares of SXTP for $9,125 on Dec 12 ’24. The Director now owns 46,078 shares after completing the transaction at $1.82 per share. On Dec 16 ’24, another insider, XU CHERYL, who serves as the Director of the company, bought 2,000 shares for $1.45 each. As a result, the insider paid 2,900 and bolstered with 54,078 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.57.
Stock Price History:
Over the past 52 weeks, SXTP has reached a high of $7.20, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -54.15%, while the 200-Day Moving Average is calculated to be -72.39%.
Shares Statistics:
A total of 1.86M shares are outstanding, with a floating share count of 1.84M. Insiders hold about 20.10% of the company’s shares, while institutions hold 6.67% stake in the company.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of 60 Degrees Pharmaceuticals Inc (SXTP) in the stock market.The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.67 and low estimates of -$0.67.
Analysts are recommending an EPS of between -$5.68 and -$5.68 for the fiscal current year, implying an average EPS of -$5.68. EPS for the following year is -$2.71, with 1.0 analysts recommending between -$2.71 and -$2.71.
Revenue Estimates
2 analysts predict $234k in revenue for the current quarter. It ranges from a high estimate of $268k to a low estimate of $200k. As of the current estimate, 60 Degrees Pharmaceuticals Inc’s year-ago sales were $125.68kFor the next quarter, 2 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 2 analysts have provided revenue estimates for SXTP’s current fiscal year. The highest revenue estimate was $645k, while the lowest revenue estimate was $600k, resulting in an average revenue estimate of $622.5k. In the same quarter a year ago, actual revenue was $253.57kBased on 2 analysts’ estimates, the company’s revenue will be $1.65M in the next fiscal year. The high estimate is $1.9M and the low estimate is $1.4M.
